Frequency of Hymenoptera-Stings in Patients Under Allergen-Specific Immunotherapy (SIT) - Full Text View

Frequency of Hymenoptera-Stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

This study is currently recruiting participants.

Verified by University of Zurich, September 2008

Sponsored by:	University of Zurich
Information provided by:	University of Zurich
ClinicalTrials.gov Identifier:	NCT00742794

Purpose

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Condition	Intervention	Phase
Hymenoptera Sting Allergy	Other: Observation	Phase IV

MedlinePlus related topics: Allergy

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	Frequency of Hymenoptera-Stings in Patients Under and After Allergen-Specific Immunotherapy: a Retrospective Data-Analysis Considering Socio-Economic Aspects

Further study details as provided by University of Zurich:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	200
Study Start Date:	August 2008
Estimated Study Completion Date:	May 2009

Groups/Cohorts	Assigned Interventions
1 Hymenoptera sting allergic patients under immunotherapy	Other: Observation Observation of sting frequency

Eligibility

Ages Eligible for Study:	5 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Hymenoptera sting allergic patients under allergen specific immunotherapy

Criteria

Inclusion criteria:

Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria:

None

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00742794

Contacts

Contact: 01 Studienregister MasterAdmins

+41 (0)44 255 11 11

Locations

Switzerland
	Recruiting
Zurich, Switzerland

Sponsors and Collaborators

University of Zurich

Investigators

Study Director:

01 Studienregister MasterAdmins

UniversitaetsSpital Zuerich

More Information

Responsible Party:	University of Zurich ( G.Senti )
Study ID Numbers:	ZU-HVA-001
Study First Received:	August 27, 2008
Last Updated:	September 8, 2008
ClinicalTrials.gov Identifier:	NCT00742794
Health Authority:	Switzerland: Swissmedic

Study placed in the following topic categories:

Hypersensitivity
Wounds and Injuries
Poisoning
Disorders of Environmental Origin
Bites and Stings

ClinicalTrials.gov processed this record on January 16, 2009